Ani Pharmaceuticals (ANIP) Other Non Operating Income (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted Other Non Operating Income of -$651000.0 for Q1 2026, down 137.44% sequentially from $1.7 million in Q2 2025, and down 428.79% YoY from $198000.0 in Q1 2025.
Ani Pharmaceuticals (ANIP) Other Non Operating Income (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Other Non Operating Income for 16 years, with the latest figure at -$651000.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 428.79% year-over-year to -$651000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 112.45% YoY) and the FY2024 annual result came in at -$4.0 million, changed N/A from the prior year.
- Other Non Operating Income eased to -$651000.0 in Q1 2026 per ANIP's latest filing, from $1.7 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.7 million in Q2 2025 and troughed at -$7.5 million in Q3 2024.
- A 5-year average of -$545923.1 and a median of -$42000.0 in 2022 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income jumped 2076.14% in 2025, then slumped 428.79% in 2026.
- Over 5 years, Other Non Operating Income stood at -$42000.0 in 2022, then decreased by 26.19% to -$53000.0 in 2023, then sank by 2500.0% to -$1.4 million in 2024, then jumped by 226.2% to $1.7 million in 2025, then tumbled by 137.44% to -$651000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$651000.0, $1.7 million, and $198000.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -468,000.00 |
| Mar 31, 2026 | -651,000.00 |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 198,000.00 |
| Dec 31, 2024 | -1.38 Mn |
| Sep 30, 2024 | -7.47 Mn |
| Jun 30, 2024 | -88,000.00 |
| Mar 31, 2024 | -32,000.00 |
| Jun 30, 2023 | -53,000.00 |
| Mar 31, 2023 | -34,000.00 |
| Dec 31, 2022 | -42,000.00 |
| Sep 30, 2022 | 37,000.00 |
| Jun 30, 2022 | 764,000.00 |
| Mar 31, 2022 | -89,000.00 |
| Dec 31, 2021 | -2.69 Mn |
| Sep 30, 2021 | -1.07 Mn |
| Jun 30, 2021 | -67,000.00 |
| Mar 31, 2021 | -515,000.00 |
| Dec 31, 2020 | -159,000.00 |
| Sep 30, 2020 | -229,000.00 |